d861773_13d.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

SCHEDULE 13D
THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No.____________)*

Genesco, Inc.
(Name of Issuer)

Common Stock, par value $1 per share
(Title of Class of Securities)
 
371532102
(CUSIP Number)

Alan Fournier
c/o Pennant Capital Management, LLC
26 Main Street, Suite 203
Chatham, NJ 07928
(Name, Address and Telephone Number of Person Authorized to Receive
Notices and Communications)

March 3, 2008
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13D-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [_].
 
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.
 
   
*   The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 

CUSIP No.
371532102
   

1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Pennant Capital Management, LLC
 

2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
   
(a)
[_]
   
(b)
[X]

3.
SEC USE ONLY
 
     
 
4.
SOURCE OF FUNDS*
 
     
 
AF
 

5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[_]
     
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
Delaware
 

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

7.
SOLE VOTING POWER
 
 
0
 

8.
SHARED VOTING POWER
 
     
 
2,000,000
 

9.
SOLE DISPOSITIVE POWER
     
 
0
 

10.
SHARED DISPOSITIVE POWER
 
[_]
     
 
2,000,000
 

11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
  2,000,000   
  
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 
 
CERTAIN SHARES*
 
     

13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
     
 
8.8%
 

14.
TYPE OF REPORTING PERSON
 
     
 
IA, OO
 


 
 

 


CUSIP No.
371532102
   
 
1.
NAME OF REPORTING PERSONS
 
 
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
     
 
Alan Fournier
c/o Pennant Capital Management, LLC
 
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
   
(a)
[_]
   
(b)
[X]
 
3.
SEC USE ONLY
 
     
 
4.
SOURCE OF FUNDS*
 
     
 
AF
 
 
5.
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
 
[_]
 
6.
CITIZENSHIP OR PLACE OF ORGANIZATION
 
     
 
United States
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
 
7.
SOLE VOTING POWER
 
     
 
0
 
 
8.
SHARED VOTING POWER
 
     
 
2,000,000
 
 
9.
SOLE DISPOSITIVE POWER
     
 
0
 
 
10.
SHARED DISPOSITIVE POWER
 
[_]
     
 
2,000,000
 
 
11.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
 
 
  2,000,000   
 
12.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
 
 
CERTAIN SHARES*
 
     
 
13.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
     
 
8.8%
 
 
14.
TYPE OF REPORTING PERSON
 
     
 
IN
 
     
 
 

 

     CUSIP No. 
371532102 
 
 
Item 1.
Security and Issuer.
 

 
The name of the issuer is Genesco, Inc.., a Tennessee corporation (the "Issuer").  The address of the Issuer's offices is 1415 Murfreesboro Road, Nashville, Tennessee 37217.  This schedule relates to the Issuer's Common Shares (the "Shares").
   
   

Item 2.
Identity and Background.
 

 
   (a-c, f) This Schedule 13D is being filed by Pennant Capital Management, LLC, a Delaware limited liability company (“Pennant Capital”), and Alan Fournier, a United States citizen (each a “Reporting Person” and collectively the “Reporting Persons”).  The principal business address of the Reporting Persons is 26 Main Street, Suite 203, Chatham, NJ 07928.  Pennant Capital serves as the investment manager of Pennant Offshore Partners, Ltd. and Pennant Windward Fund, Ltd., each a Cayman Islands investment fund, and to Pennant Onshore Partners, LP,; Pennant Onshore Qualified, LP, Pennant Spinnaker Fund, LP, and Pennant Windward Fund, LP, each a Delaware investment fund (each a “Fund” and collectively the “Funds”).  Mr. Fournier serves as the managing member of Pennant Capital and is primarily responsible for all investment decisions regarding each Fund’s investment portfolio.  The Shares reported herein are held in the portfolios of the Funds.

 
(d)
Alan Fournier has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
       
 
(e)
None of the Reporting Persons have, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding were or are subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.
         
       

Item 3.
Source and Amount of Funds or Other Consideration.
 

 
As of the date hereof Pennant Capital Management, LLC may be deemed to beneficially own 2,000,000 Shares.
 
As of the date hereof Alan Fournier may be deemed to beneficially own 2,000,000 Shares.
 
No borrowed funds were used to purchase the Shares reported herein, other than any borrowed funds used for working capital purposes in the ordinary course of business.
   
 
 


 
Item 4.
Purpose of Transaction.
 

 
The Reporting Persons acquired their Shares of the Issuer for investment purposes.
 
The Reporting Persons have no plans or proposals which, other than as expressly set forth below, would relate to or would result in: (a) the acquisition of additional securities of the Issuer or the disposition of presently-owned securities of the Issuer; (b) any extraordinary corporate transaction involving the Issuer; (c) a sale or transfer of a material amount of assets of the Issuer; (d) any change in the present Board of Directors or management of the Issuer; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any material change in the operating policies or corporate structure of the Issuer; (g) any change in the Issuer’s charter or by-laws; (h) the Shares of the Issuer ceasing to be authorized to be quoted in the over-the-counter security markets; or (i) causing the Issuer to become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934.  The Reporting Persons, however, reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own.
 
The Reporting Persons have been and may continue to be in contact with members of the Issuer’s management, the Issuer’s Board of Directors, other significant shareholders and others regarding alternatives that the Issuer could employ to improve shareholder value including, but not limited to, the resolution of the Issuer’s current regulatory issues, its plans with respect to financial matters, improving the composition of the Board of Directors if they lack the skills and experience needed in order to handle the difficult and complex challenges that the Issuer currently faces, the implementation of corporate governance reforms and changes in the Issuer’s management.
 

Item 5.
Interest in Securities of the Issuer.
 
     
 
As of the date hereof, the Reporting Persons may be deemed to beneficially own 2,000,000 Shares, or 8.8% of the Shares of the Issuer, based upon the 22,795,681 Shares outstanding as of November 30, 2007, according to the Issuer’s most recent Form 10-Q filing.
 
Pennant Capital Management, LLC shares the power to vote or direct the vote of 2,000,000 Shares to which this filing relates.
 
Pennant Capital Management, LLC has the sole power to vote or direct the vote of 0 Shares to which this filing relates.
 
Pennant Capital Management, LLC shares the power to dispose or direct the disposition of the 2,000,000 Shares to which this filing relates.
 
Pennant Capital Management, LLC has the sole power to dispose or direct the disposition of 0 Shares to which this filing relates.
 
Pennant Capital Management, LLC specifically disclaims beneficial ownership in the Shares reported herein except to the extent of its pecuniary interest therein.
 
Alan Fournier shares the power to vote or direct the vote of 2,000,000 Shares to which this filing relates.
 
Alan Fournier has the sole power to vote or direct the vote of 0 Shares to which this filing relates.
 
Alan Fournier shares the power to dispose or direct the disposition of the 2,000,000 Shares to which this filing relates.
 
Alan Fournier has the sole power to dispose or direct the disposition of 0 Shares to which this filing relates.
 
 

 

 
 
Alan Fournier specifically disclaims beneficial ownership in the Shares reported herein except to the extent of his pecuniary interest therein. 
 
 
  Each of the Reporting Persons has the right to receive and the power to direct the receipt of dividends from, or the proceeds from the sale of, a portion of the Shares reported herein.   
 
 
The trading dates, number of shares purchased and sold and price per share for all transactions in the Shares during the past 60 days by the Reporting Persons on behalf of the Funds were all effected in broker transactions as set forth on Exhibit B. 
 
     
 
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect
 
 
to Securities of the Issuer.
 

 
The Reporting Persons do not have any contract, arrangement, understanding or relationship with any person with respect to the Shares.
 
     
     

Item 7.
Material to be Filed as Exhibits.
 

 
Exhibit A: Agreement between the Reporting Persons to file jointly
 
Exhibit B: Schedule of Transactions in the Shares of the Issuer
 
 
     


 
 

 


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
March 6, 2007
 
(Date)
   
 
PENNANT CAPITAL MANAGEMENT, LLC*
   
 
 
/s/ Alan Fournier
 
Name: Alan Fournier
Title: Managing Member
   
   
  ALAN FOURNIER* 
   
 
/s/ Alan Fournier__________________________
 
Alan Fournier 
   


Attention:  Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

 
 

 

Exhibit A
 
JOINT FILING AGREEMENT

Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of Common Shares of Genesco Inc.
 
This Agreement may be executed in any number of counterparts, each of which shall be deemed an original.
 
Executed this 6th day of March, 2008.
 

 
PENNANT CAPITAL MANAGEMENT, LLC*
   
 
 
/s/ Alan Fournier
 
Name: Alan Fournier
Title: Managing Member
   
   
  ALAN FOURNIER* 
   
 
/s/ Alan Fournier__________________________
 
Alan Fournier 
   

* The Reporting Persons disclaim beneficial ownership over the securities reported herein except to the extent of the reporting persons’ pecuniary interest therein.


 
 

 

Exhibit B
 
TRANSACTIONS IN THE SHARES


 
 
Date of Transaction
 
Number of Shares Purchased/(Sold)
 
Price of Shares
     
1/8/2008
75,000
31.91
1/9/2008
22,502
31.73
1/10/2008
28,200
31.78
1/11/2008
79,298
32.75
1/14/2008
70,000
32.92
1/15/2008
111,600
30.73
1/16/2008
38,400
30.07
1/17/2008
250,000
29.12
1/18/2008
84,400
28.90
1/22/2008
95,600
29.24
1/23/2008
50,000
28.34
3/3/2008
917,400
23.98







SK 03461 0004 861773